Clinical Trials Browser

Active not recruiting × Interventional × Papillomavirus Infections × Clear all

NCT06256718 2026-03-17

Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care

Phase NA Active not recruiting

Papillomavirus Infections

NCT03036930 2026-03-11

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Phase 2 Active not recruiting

51 enrolled 10 charts

Papillomavirus Infections

NCT07217145 2026-03-09

PREVENT HPV -Related Cancers Trial

Phase NA Active not recruiting

Behavior, Communication, Neoplasms, Patient Acceptance of Health Care, Papillomavirus Infections

NCT06491446 2026-02-18

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Phase 1/2 Active not recruiting

Sexually Transmitted Diseases, Papillomavirus Infections

NCT04206813 2026-01-27

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Phase 4 Active not recruiting

Papillomavirus Infections

NCT05797246 2026-01-26

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Phase 2 Active not recruiting

DNA Virus Infections, Infections, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Pathologic Processes, Recurrence, Respiratory Tract Diseases, Respiratory Tract Infections, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Disease Attributes, Papillomavirus Infections

NCT04255849 2026-01-23

Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

Phase 3 Active not recruiting

Papillomavirus Infections

NCT06632912 2026-01-23

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

Phase 3 Active not recruiting

Infections, Papillomavirus Infections

NCT05057312 2026-01-21

Promoting HPV Vaccination Among Young Adults in Texas

Phase NA Active not recruiting

Papillomavirus Infections

NCT06302725 2026-01-15

APOSY

Phase NA Active not recruiting

Papillomavirus Infections

NCT01901770 2026-01-12

PARENT

Phase NA Active not recruiting

Papillomavirus Infections

NCT07200414 2026-01-07

SHARP

Phase NA Active not recruiting

14,768 enrolled

Infections, Papillomavirus Infections

NCT04124198 2025-12-31

QoLATI

Phase NA Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, DNA Virus Infections, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Oropharyngeal Neoplasms, Otorhinolaryngologic Diseases, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Papillomavirus Infections

NCT06611540 2025-12-30

LMI-001-A-S03

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06611553 2025-12-15

LMI-001-A-S02

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06162676 2025-12-03

Game-Based Intervention to Promote HPV Vaccination

Phase NA Active not recruiting

Vaccine-Preventable Diseases, Papillomavirus Infections

NCT06002126 2025-11-14

ULACNet-202

Phase NA Active not recruiting

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT06577220 2025-10-14

Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04953130 2025-09-10

Add-Vacc

Phase 4 Active not recruiting

10,400 enrolled

Vaccine-Preventable Diseases, Papillomavirus Infections

NCT03180034 2025-09-04

ESCUDDO

Phase 4 Active not recruiting

27,945 enrolled

Papillomavirus Infections

NCT02816879 2025-07-29

Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men

Phase NA Active not recruiting

Gastrointestinal

Anus Neoplasms, HIV Infections, Papillomavirus Infections

NCT04724980 2025-06-11

Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

Phase 1/2 Active not recruiting

Recurrent respiratory papillomatosis, Papillomavirus Infections

NCT05555862 2025-05-18

anal HSIL HIV-

Phase 2 Active not recruiting

Papillomavirus Infections

NCT06959563 2025-05-13

9vHPV-BCG

Phase EARLY_PHASE1 Active not recruiting

Papillomavirus Infections

NCT04708041 2025-04-20

V503-069

Phase 3 Active not recruiting

Papillomavirus Infections

NCT06452004 2025-04-04

AI-DSS

Phase NA Active not recruiting

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04235257 2025-03-27

Intradermal, Fractional Dose of HPV Vaccines:

Phase 4 Active not recruiting

Papillomavirus Infections

NCT05291871 2025-03-27

Immunogenicity of Fractional Dose of the HPV Vaccines

Phase 4 Active not recruiting

Papillomavirus Infections

NCT04199689 2025-03-25

V503-049

Phase 3 Active not recruiting

Papillomavirus Infections

NCT01898494 2025-02-28

Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

Phase 2 Active not recruiting

519 enrolled 16 charts

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT06454175 2025-01-06

A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

Phase 1 Active not recruiting

Condylomata Acuminata, Papillomavirus Infections

NCT05285826 2024-12-16

Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)

Phase 3 Active not recruiting

Papillomavirus Infections

NCT04270773 2024-07-10

9-VPH-MVIH

Phase 4 Active not recruiting

HIV Infections, Papillomavirus Infections

NCT00892866 2024-05-03

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

Phase NA Active not recruiting

Uterine Cervical Dysplasia, Endometrial Hyperplasia, Papillomavirus Infections

NCT04794660 2024-03-13

CESTA

Phase 3 Active not recruiting

Papillomavirus Infections

NCT06041061 2023-09-18

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years

Phase 3 Active not recruiting

18,000 enrolled

Papillomavirus Infections

NCT05662020 2022-12-27

A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Phase 3 Active not recruiting

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT03998254 2022-11-16

V503-023

Phase 3 Active not recruiting

Papillomavirus Infections

NCT05450705 2022-09-02

V503-071

Phase 3 Active not recruiting

Papillomavirus Infections